BY REBECCA ROBBINS AND ANA SWANSON

New York Times

President Trump likes to talk about taking on the biggest pharmaceutical companies and bringing manufacturing home. But with his long-awaited announcement Thursday to impose tariffs of 100% on imported brand-name medicines, the president appeared to have given many of the richest companies a reprieve.

Giant companies that make brand-name drugs do a significant majority of that manufacturing in either the United States or Europe. Among the best known are Botox, formulated in Ireland, as well as popular weight-loss drugs, produced in Denmark, Ireland and the United States.

Trump's 100% tariff, expected to go into effect Oct. 1, would not apply to drugs from the European Union. Instead, most of those brand-name products from the E.U. are e

See Full Page